| Features: | |||||||||||||||||||||||||||||||||||||||||||||||||
| Coenzyme Q10 (CoQ10), also known as ubiquinone, is a fat-soluble antioxidant and a critical component of the mitochondrial electron transport chain, essential for ATP production. Its potential role in Alzheimer’s disease (AD) and cancer has been increasingly studied, mainly due to its effects on oxidative stress, mitochondrial function, and cellular energy metabolism. Two types: ubiquinone(standard) vs ubiquinol(more bioavailable) -high content in beef heart -Acts as an antioxidant, reducing ROS -Some preclinical studies suggest CoQ10 may reduce Aβ-induced neurotoxicity -CoQ10 is sometimes used with chemotherapy to reduce cardiotoxicity (especially with doxorubicin). -Essential for ATP (energy) production. -CoQ10 levels may drop by 25–40% in people taking statins. -May support mitochondrial function in neurodegenerative diseases, including Alzheimer’s and Parkinson’s Coenzyme Q10 exists in three redox states: Form Name Abbreviation Redox state Oxidized Ubiquinone CoQ10 Oxidized (labeled “Coenzyme Q10”, “CoQ10”) Semiquinone Ubiquinol radical CoQ10•– Intermediate (labeled “Ubiquinol”, “Reduced CoQ10”) Reduced Ubiquinol CoQ10H₂ Reduced Most supplements = ubiquinol (reduced, antioxidant) Ubiquinol is often preferred for cardiovascular, aging, and antioxidant-focused use. BPM31510 = ubiquinone (oxidized) (might raise ROS in cancer cells) >80–95% of circulating CoQ10 is ubiquinol, regardless of whether ubiquinone or ubiquinol was ingested -CoQ10 is fat-soluble, so take it alongside meals that include nutrient-dense fats like coconut oil, butter or tallow in moderation -initial 200-300mg/day (split during day) down to 100mg after 21 days BPM31510: Pharmaceutical oxidized CoQ10 BPM31510 = oxidized CoQ10 (ubiquinone) in a specialized lipid formulation. BPM31510 increases Mitochondrial ROS in cancer cells. That increase is intentional, central to its mechanism, and relatively selective for tumor cells. BPM31510 Studies report in cancer cells: ↑ mitochondrial ROS ↑ lipid peroxidation ↓ NADPH/NADP⁺ ratio ↓ GSH/GSSG ratio Activation of oxidative stress pathways Cell death without classic antioxidant rescue Importantly: Trolox, NAC, or GSH can partially blunt BPM31510 effects, confirming ROS dependence Coenzyme Q10 (CoQ10 / Ubiquinone) — Cancer vs Normal Cell Effects
|
| Source: |
| Type: |
| Hypoxia-Inducible-Factor 1A (HIF1A gene, HIF1α, HIF-1α protein product) -Dominantly expressed under hypoxia(low oxygen levels) in solid tumor cells -HIF1A induces the expression of vascular endothelial growth factor (VEGF) -High HIF-1α expression is associated with Poor prognosis -Low HIF-1α expression is associated with Better prognosis -Functionally, HIF-1α is reported to regulate glycolysis, whilst HIF-2α regulates genes associated with lipoprotein metabolism. -Cancer cells produce HIF in response to hypoxia in order to generate more VEGF that promote angiogenesis Key mediators of aerobic glycolysis regulated by HIF-1α. -GLUT-1 → regulation of the flux of glucose into cells. -HK2 → catalysis of the first step of glucose metabolism. -PKM2 → regulation of rate-limiting step of glycolysis. -Phosphorylation of PDH complex by PDK → blockage of OXPHOS and promotion of aerobic glycolysis. -LDH (LDHA): Rapid ATP production, conversion of pyruvate to lactate; HIF-1α Inhibitors: -Curcumin: disruption of signaling pathways that stabilize HIF-1α (ie downregulate). -Resveratrol: downregulate HIF-1α protein accumulation under hypoxic conditions. -EGCG: modulation of upstream signaling pathways, leading to decreased HIF-1α activity. -Emodin: reduce HIF-1α expression. (under hypoxia). -Apigenin: inhibit HIF-1α accumulation. |
| - | in-vitro, | CRC, | NA |
Query results interpretion may depend on "conditions" listed in the research papers. Such Conditions may include : -low or high Dose -format for product, such as nano of lipid formations -different cell line effects -synergies with other products -if effect was for normal or cancerous cells
Filter Conditions: Pro/AntiFlg:% IllCat:% CanType:% Cells:% prod#:356 Target#:143 State#:% Dir#:1
wNotes=0 sortOrder:rid,rpid